Exact Mass: 307.98481519999996
Exact Mass Matches: 307.98481519999996
Found 149 metabolites which its exact mass value is equals to given mass value 307.98481519999996,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
(R)-5-Diphosphomevalonic acid
Mevalonate-diphosphate, also known as 5-diphosphomevalonic acid or mevelonic acid-5-diphosphoric acid, is a member of the class of compounds known as organic pyrophosphates. Organic pyrophosphates are organic compounds containing the pyrophosphate oxoanion, with the structure OP([O-])(=O)OP(O)([O-])=O. Thus, mevalonate-diphosphate is considered to be a fatty acid lipid molecule. Mevalonate-diphosphate is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Mevalonate-diphosphate can be found in a number of food items such as kohlrabi, enokitake, avocado, and redcurrant, which makes mevalonate-diphosphate a potential biomarker for the consumption of these food products. Mevalonate-diphosphate exists in all eukaryotes, ranging from yeast to humans. In humans, mevalonate-diphosphate is involved in several metabolic pathways, some of which include zoledronate action pathway, lovastatin action pathway, pamidronate action pathway, and desmosterolosis. Mevalonate-diphosphate is also involved in several metabolic disorders, some of which include wolman disease, lysosomal acid lipase deficiency (wolman disease), cholesteryl ester storage disease, and CHILD syndrome. 5-Diphosphomevalonic acid (CAS: 1492-08-6) is a metabolic intermediate in the mevalonate pathway, catalyzed by the enzyme phosphomevalonate kinase from 5-phosphomevalonate (Wikipedia).
FENSULFOTHION
CONFIDENCE standard compound; INTERNAL_ID 348; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8595; ORIGINAL_PRECURSOR_SCAN_NO 8592 CONFIDENCE standard compound; INTERNAL_ID 348; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8562; ORIGINAL_PRECURSOR_SCAN_NO 8559 CONFIDENCE standard compound; INTERNAL_ID 348; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8609; ORIGINAL_PRECURSOR_SCAN_NO 8605 CONFIDENCE standard compound; INTERNAL_ID 348; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8582; ORIGINAL_PRECURSOR_SCAN_NO 8581 CONFIDENCE standard compound; INTERNAL_ID 348; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8608; ORIGINAL_PRECURSOR_SCAN_NO 8606 CONFIDENCE standard compound; INTERNAL_ID 348; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8628; ORIGINAL_PRECURSOR_SCAN_NO 8627
Alphachloralose
C8H11Cl3O6 (307.96211960000005)
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics Bird repellant in grain seed
(R)-3,5-bisphosphomevalonic acid
(R)-Mevalonic acid-5-pyrophosphate
(R)-Mevalonic acid-5-pyrophosphate (mevalonate 5-diphosphate) is a directly synthesized product of mevalonate phosphate that is essential for cell proliferation. (PMID 2211719). It is a substrate for mevalonate-5-diphosphate decarboxylase, the third enzyme involved in the biosynthesis of cholesterol from mevalonic acid. This enzyme catalyzes the reaction of mevalonate 5-diphosphate (MVADP) with ATP to produce isopentenyl diphosphate, ADP, CO2, and inorganic phosphate. The overall reaction involves an anti elimination of the tertiary hydroxyl and carboxyl groups. This metabolite participates both in the biosynthesis of cholesterol and fatty acid mechanism, through which interpathway regulation could take place between the cholesterol and FA cascades. (PMID 8769113 ) [HMDB] (R)-Mevalonic acid-5-pyrophosphate (mevalonate 5-diphosphate) is a directly synthesized product of mevalonate phosphate that is essential for cell proliferation. (PMID 2211719). It is a substrate for mevalonate-5-diphosphate decarboxylase, the third enzyme involved in the biosynthesis of cholesterol from mevalonic acid. This enzyme catalyzes the reaction of mevalonate 5-diphosphate (MVADP) with ATP to produce isopentenyl diphosphate, ADP, CO2, and inorganic phosphate. The overall reaction involves an anti elimination of the tertiary hydroxyl and carboxyl groups. This metabolite participates both in the biosynthesis of cholesterol and fatty acid mechanism, through which interpathway regulation could take place between the cholesterol and FA cascades. (PMID 8769113 ).
(1E,4R,6S)-1,6-Dibromo-1,3(8)-ochtodien-4-ol
(1E,4S,6S)-1,6-Dibromo-1,3(8)-ochtodien-4-ol
5-bromo-7-(trifluoromethyl)-1,4-dihydroquinoxaline-2,3-dione
C9H4BrF3N2O2 (307.94082199999997)
ascidiathiazone A
An organic heterotricyclic compound, that is 3,4-dihydro-2H-[1,4]thiazino[2,3-g]quinoline-5,10 dione S,S-dioxide substituted at position 7 by a carboxyl group. It is an anti-inflmmatory alkaloid obtained from Aplidium.
1,3-Bis-(2-chlor-1,1,2-trifluor-aethoxy)-propan|1,3-bis-(2-chloro-1,1,2-trifluoro-ethoxy)-propane
1,2,3-Trihydroxy-6-methoxy-7-chloro-9H-xanthene-9-one
(E)-5-(1-Acetoxy-2-chloro-1-buten-3-ynyl)-2,2?脣-bithiophene
8-bromoethoxypsoralen|9-(2-bromo-ethoxy)-furo[3,2-g]chromen-7-one|9-(2-bromoethoxy)-2H-furo[3,2-g]chromen-2-one|9-(2-bromoethoxy)-7H-furo[3,2-g]chromen-7-one
1,1,1-TRICHLORO-4-HYDROXY-11-METHYLDODECA-3,5,7,9-TETRAEN-2-ONE
Chloralose
C8H11Cl3O6 (307.96211960000005)
CONFIDENCE standard compound; INTERNAL_ID 571; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3386; ORIGINAL_PRECURSOR_SCAN_NO 3383 D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent CONFIDENCE standard compound; INTERNAL_ID 571; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3405; ORIGINAL_PRECURSOR_SCAN_NO 3400 CONFIDENCE standard compound; INTERNAL_ID 571; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3382; ORIGINAL_PRECURSOR_SCAN_NO 3379 CONFIDENCE standard compound; INTERNAL_ID 571; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3401; ORIGINAL_PRECURSOR_SCAN_NO 3398 CONFIDENCE standard compound; INTERNAL_ID 571; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3393; ORIGINAL_PRECURSOR_SCAN_NO 3392 CONFIDENCE standard compound; INTERNAL_ID 571; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3387; ORIGINAL_PRECURSOR_SCAN_NO 3385
alpha-D-Glucofuranose,1,2-O-[(1S)-2,2,2-trichloroethylidene]-
C8H11Cl3O6 (307.96211960000005)
3-Bromo-4-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)benzoic acid
C12H9BrN2O3 (307.97965039999997)
Pyrimido[4,5-g]quinazoline-4,9-dione,2-(chloromethyl)-1,6-dihydro-5,10-dihydroxy-7-methyl- (9CI)
C12H9ClN4O4 (308.03123039999997)
cycloheptatrienyliumchromium tricarbonyl tetrafluoroborate
[6-(4-bromophenyl)imidazo[2,1-b][1,3]thiazol-5-yl]methanol
ETHYL 5-BROMO-1-(4-METHYLPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE
Propanimidic acid,3,3-dithiobis-, 1,1-dimethyl ester, hydrochloride (1:2)
C8H18Cl2N2O2S2 (308.01867080000005)
4-BROMO-3-FLUORO-4-METHOXYBENZOPHENONE
C14H10BrFO2 (307.98481519999996)
2-phosphonobutane-1,2,4-tricarboxylic acid, potassium salt
C7H10KO9P (307.96995200000003)
5-bromo-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinonitrile
Poly(oxy-1,2-ethanediyl), .alpha.-phosphono-.omega.-(methylphenoxy)-, dipotassium salt
2-(3,5-dichlorophenoxy)-5-nitrobenzonitrile
C13H6Cl2N2O3 (307.97554660000003)
[2,6-dichloro-4-(trifluoromethylsulfonyl)phenyl]hydrazine
5-[2,6-DICHLORO-4-(TRIFLUOROMETHYL)PHENYL]-2-FURALDEHYDE
ethyl 3-(4-bromophenyl)-1-methyl-1h-pyrazole-5-carboxylate
BOC-(1S,2R)-(+)-2-AMINOCYCLOHEX-4-ENE-CARBOXYLIC ACID
C14H10BrFO2 (307.98481519999996)
5-(4-bromophenyl)-1-(tetrahydro-2H-pyran-2-yl)tetrazole
5-[3-(TRIFLUOROMETHYL)BENZYLTHIO]-1,3,4-THIADIA-ZOLE-2-THIOL
ETHYL 4-(4-CHLOROPHENYL)-5-CYANAMIDE-4,5-DIHYDRO-1,3,4-THIADIAZOLE-2-CARBOXYLATE
6-(3-BROMO-PHENYL)-4-CHLORO-FURO[2,3-D]PYRIMIDINE
C12H6BrClN2O (307.93519960000003)
6-(4-BROMO-PHENYL)-4-CHLORO-FURO[2,3-D]PYRIMIDINE
C12H6BrClN2O (307.93519960000003)
2-ACETYL-2H-INDAZOL-7-YL TRIFLUOROMETHANESULFONATE
C10H7F3N2O4S (308.00786180000006)
Benzene,1,1-[(1E)-1,2-ethenediylbis(sulfonyl)]bis-
Zinc Picolinate
C12H8N2O4Zn (307.97754979999996)
D064449 - Sequestering Agents > D002614 - Chelating Agents > D007502 - Iron Chelating Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
1-(3-bromophenyl)-4-chloropyrazolo[3,4-d]pyrimidine
C11H6BrClN4 (307.94643260000004)
1-(4-Bromophenyl)-4-chloro-1H-pyrazolo[3,4-d]pyrimidine
C11H6BrClN4 (307.94643260000004)
2-mercapto-5-(4-sulfobutyl)thio-1,3,4-thiadiazole sodium salt
3-[2-(2,4-Dichlorophenoxy)phenyl]acrylic acid
C15H10Cl2O3 (308.00069700000006)
(3-BOC-AMINO-PYRROLIDIN-1-YL)-(1H-INDOL-2-YL)-ACETICACID
6-amino-3-(2,6-dichlorophenyl)-1-methylpyrazolo[1,5-a]pyrimidin-2-one
(5-Bromo-pyrimidin-2-yl)-(4-methyl-3-nitro-phenyl)-amine
2-[(4-CHLOROPHENYL)THIO]-5-NITROBENZOIC ACID
C13H7ClNO4S- (307.97843120000005)
5-(4-Chlorophenyl)-2-(trifluoromethyl)furan-3-carbonyl chloride
3-BENZYLOXY-6-BROMO-2-FLUOROBENZALDEHYDE
C14H10BrFO2 (307.98481519999996)
3-BROMO-3-FLUORO-4-METHOXYBENZOPHENONE
C14H10BrFO2 (307.98481519999996)
2-(4-Chlorophenyl)-3-(trifluoromethyl)pyrazole-4-carbonyl chloride
Methyl 4-((5-bromopyrimidin-2-yl)oxy)benzoate
C12H9BrN2O3 (307.97965039999997)
3-[(4-Bromo-3,5-dimethyl-1H-pyrazol-1-yl)methyl]-benzoic acid
4-HYDROXY-3-IODO-5-METHOXYBENZOIC ACID METHYL ESTER
4,5-Dichloro-2-(4-(trifluoromethyl)phenyl)pyridazin-3(2H)-one
5-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]-2-FURALDEHYDE
C13H6F6O2 (308.02719679999996)
2-Bromo-1-(2,4-dichlorophenyl)pentan-1-one
C11H11BrCl2O (307.93702759999996)
D-Gluco-2,5-anhydro-1-deoxy-1-phosphonohexitol-6-phosphate
S-(4-chlorophenyl) 3,4-dimethoxybenzenecarbothioate
C15H13ClO3S (308.02738980000004)
5-(4-bromophenyl)-N-propan-2-yl-3-isoxazolecarboxamide
N,N-dimethylcarbamodithioic acid (1-acetamido-2,2,2-trichloroethyl) ester
(R)-5-Diphosphomevalonic acid
The 5-diphospho derivative of (R)-mevalonic acid.
(3S)-3-hydroxy-5-{[hydroxy(phosphonooxy)phosphoryl]oxy}-3-methylpentanoic acid
BTYNB
BTYNB is a potent and selective inhibitor of IMP1 binding to c-Myc mRNA (IC50=5 μM). BTYNB exhibits selectivity and effectiveness against IMP1-postive cancer cell lines. BTYNB can be used for cancer research[1].
IC87201
IC87201, an inhibitor of PSD95-nNOS protein-protein interactions, suppresses NMDAR-dependent NO and cGMP formation.
TC-S 7009
TC-S 7009 is a potent and selective HIF-2α inhibitor with a Kd of 81 nM. TC-S 7009 is more selective for HIF-2α than HIF-1α (Kd ? 5 μM). TC-S 7009 disrupts HIF-2α heterodimerization, decreases DNA-binding activity, and reduces HIF-2α target gene expression[1][2].
(4s,6r,7ar)-4,6-dibromo-5,5-dimethyl-4,6,7,7a-tetrahydro-2h-1-benzofuran
7-chloro-1,2,3-trihydroxy-6-methoxyxanthone
{"Ingredient_id": "HBIN013134","Ingredient_name": "7-chloro-1,2,3-trihydroxy-6-methoxyxanthone","Alias": "NA","Ingredient_formula": "C14H9ClO6","Ingredient_Smile": "COC1=C(C=C2C(=C1)OC3=CC(=C(C(=C3C2=O)O)O)O)Cl","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "3573","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
methyl 2-chloro-1,8-dihydroxy-9-oxocyclopenta[b]chromene-1-carboxylate
(2e,4r,6r)-4,6-dibromo-3,7-dimethylocta-2,7-dienal
4,4,5,10-tetraoxo-1h,2h,3h-4λ⁶-[1,4]thiazino[3,2-g]quinoline-7-carboxylic acid
6-(1-bromoprop-1-en-1-yl)-1-chloro-5-hydroxy-4-methoxy-7-oxabicyclo[4.1.0]hept-3-en-2-one
5-chloro-2-[3-(dichloromethylidene)hexyl]benzene-1,3-diol
(1r,11r)-11-(hydroxymethyl)-15-methyl-12,13-dithia-9,15-diazatetracyclo[9.2.2.0¹,⁹.0³,⁸]pentadeca-3,5,7-triene-10,14-dione
(1r,5s)-5-bromo-2-[(1e)-2-bromoethenyl]-4,4-dimethylcyclohex-2-en-1-ol
8-amino-2-carbamoyl-7-chloro-n-methyl-5,6-dioxoquinoline-4-carboximidic acid
C12H9ClN4O4 (308.03123039999997)